San Donato Hospital
| Italia | Turchia | Austria | |
| Trapianto di midollo osseo allogenico da donatore non correlato | da $150,000 | da $80,000 | da $180,000 |
| Trapianto di midollo osseo allogenico da donatore consanguineo | da $120,000 | da $65,000 | da $150,000 |
| Trapianto di midollo osseo | da $95,000 | da $36,000 | da $140,000 |
| Trapianto autologo di midollo osseo | da $90,000 | da $31,500 | da $50,000 |
| Terapia con cellule CAR-T | da $350,000 | da $150,000 | da $350,000 |
Bookimed non aggiunge costi extra ai prezzi dei trattamenti di Linfoma. Le tariffe provengono dai listini ufficiali delle cliniche. Pagherai direttamente in clinica al tuo arrivo nel paese.
Bookimed si impegna per la tua sicurezza. Lavoriamo solo con strutture che mantengono elevati standard internazionali nei trattamenti di Linfoma e hanno le licenze necessarie per servire pazienti internazionali in tutto il mondo.
Bookimed offre assistenza esperta gratuita. Un coordinatore medico personale ti supporta prima, durante e dopo il trattamento, risolvendo qualsiasi problema. Non sarai mai solo nel tuo percorso di trattamento per Linfoma.
Capo del Dipartimento di Trapianto di Midollo Osseo al San Raffaele – uno dei maggiori centri in Italia con oltre 90 trapianti annuali. Specializzato nel trattamento dei linfomi.
Direttore dell'Unità Linfomi presso l'Istituto Scientifico San Raffaele – Il Prof. Ferreri ha fondato la Fondazione Italiana Linfomi dedicata agli studi clinici nella gestione dei linfomi.
Responsabile di Ematologia e Trapianto di Midollo Osseo al San Raffaele – guida studi clinici su terapia cellulare e genica per i tumori del sangue.
Lymphoma treatment in Italy is world-class. Leading centers like San Raffaele specialize in advanced therapies. Facilities often hold Joint Commission International and IRCCS accreditations. Italian oncology centers report up to 85% survival rates for early-stage cases. Experts perform over 52,000 operations annually in top Milanese hospitals.
Bookimed Expert Insight: Italian research hospitals offer unique value by combining academic research with clinical care. Dr. Fabio Ciceri and Dr. Jacopo Peccatori focus on complex cell and gene therapies. Their unit performs 90 allogeneic transplants annually. This high volume often leads to better outcomes in rare lymphoma subtypes. Patients should prioritize Milan-based clinics for the highest concentration of specialized hematological expertise.
Patient Consensus: Patients note the medical staff are very professional and empathetic. Many travelers emphasize that the personalized care and technology match top US centers.
Advanced CAR T-cell therapy is available in Italy for lymphoma patients. Specialized centers like San Raffaele in Milan and Gemelli in Rome provide these innovative treatments. Eligibility is managed through the AIFA Registry. Patients often access these therapies for conditions like DLBCL after other treatments fail.
Bookimed Expert Insight: San Raffaele Hospital is a premier choice for complex hematology due to its high volume and research depth. Professor Fabio Ciceri and Professor Andres Jose Maria Ferreri have published over 480 scientific papers combined. This academic focus ensures patients access the latest lymphoma protocols and clinical trials not available at standard hospitals. Their success in performing the worlds first stem cell therapy for ADA-SCID highlights their expertise in genetic and cellular medicine.
Patient Consensus: Patients note that while the process can take 2 to 3 months for approval, the results are life-saving after a relapse. Those from southern regions mentioned they often relocate to northern cities like Milan or Bologna to access these specialized treatments more quickly.
Italy reports high lymphoma success rates. Hodgkin lymphoma centers achieve 92.5% survival for first-line therapies. Specialized units report 100% cure rates for low-risk Burkitt lymphoma. Italian oncologists utilize CAR T-cell therapy and allogeneic bone marrow transplants to improve outcomes for advanced cases.
Bookimed Expert Insight: Data shows Milan is the primary hub for complex lymphoma care. San Raffaele Hospital performs 90 allogeneic transplants annually. Dr. Andres Jose Maria Ferreri founded the Italian Lymphoma Foundation to standardize high success rates. Choosing research-heavy IRCCS institutions ensures access to the latest cell and gene therapy protocols.
Patient Consensus: Patients note that Italian clinics offer survival outcomes matching Nordic standards. Many find that private care provides significantly faster access to specialists than international public systems.
Top specialized lymphoma centers in Italy include San Raffaele Hospital and Fondazione IRCCS Istituto Nazionale dei Tumori in Milan. These facilities hold IRCCS accreditation for combining research with clinical care. They offer advanced therapies such as CAR T-cell therapy and bone marrow transplants for complex hematological cases.
Bookimed Expert Insight: San Raffaele Hospital offers a unique advantage for patients with rare or resistant lymphoma. Professor Andres Ferreri, the founder of the Italian Lymphoma Foundation, leads the Lymphoma Unit there. Our data shows his department performs 90 related and unrelated allogeneic transplants every year. This high volume directly correlates with their expertise in managing complex stem cell therapies and rare immune disorders.
Patient Consensus: Patients note that traveling to northern university hospitals often speeds up treatment by months. Many specifically recommend finding specialists like those at San Raffaele who are empathetic and highly professional.
International patients can access specialized lymphoma treatment in Italy by choosing private healthcare pathways. Non-EU citizens typically require a Schengen Medical Visa and a hospital invitation. Facilities like San Raffaele in Milan provide advanced hematology care including bone marrow transplants and CAR T-cell therapy.
Bookimed Expert Insight: While the Italian public system is resident-focused, seeking care at IRCCS-accredited research hospitals like San Raffaele ensures access to clinical trials. Dr. Jacopo Peccatori at this facility performs 90 allogeneic transplants yearly. This volume-to-outcome ratio is a primary quality indicator for international patients seeking hematological stability.
Patient Consensus: Patients note it's important to book private clinics to avoid the months-long waits found in the public system. The medical staff is described as empathic, professional, and very nice in modern, well-equipped Milanese facilities.